UMEM Educational Pearls

Blood Pressure Management in Acute Ischemic Stroke

  • Blood pressure (BP) is elevated in many patients who present to the ED with an acute ischemic stroke (AIS).
  • Severe elevations in BP are associated with hemorrhagic transformation, as well as cardiac and renal complications.
  • As such, it is important to know the various BP goals for patients with an AIS.
    • Permissive hypertension with a BP less than or equal 220/120 mm Hg is recommended for patients not receiving IV-tPA or endovascular therapy.
    • BP should be lowered to less than or equal to 180/105 mm Hg for patients who have received IV-tPA.
    • BP goals for patients who have received endovascular therapy remain controversial and should be individualized based on the degree of recanalization.

Show References



Category: Orthopedics

Title: Carpal Tunnel Syndrome

Keywords: Carpal Tunnel Syndrome, neuropathy (PubMed Search)

Posted: 10/10/2020 by Brian Corwell, MD (Updated: 5/16/2024)
Click here to contact Brian Corwell, MD

Carpal Tunnel Syndrome (CTS)

 

The hallmark of classic CTS:  pain or paresthesia (numbness and tingling) in a distribution that includes the median nerve territory, with involvement of the first three digits and the radial half of the fourth digit.

The symptoms of CTS are typically worse at night and often awaken patients from sleep.

Fixed sensory loss is usually a late finding

Involves the median-innervated fingers BUT spares the thenar eminence.

This pattern occurs because the palmar sensory cutaneous nerve arises proximal to the wrist and passes over, rather than through, the carpal tunnel.

Consider a more proximal lesion in cases involving sensory loss in the thenar eminence

            Example: pronator syndrome

 

 



Category: Pharmacology & Therapeutics

Title: Nitroglycerin Drug-Drug Interactions

Keywords: nitroglycerin, hypotension, PDE5 inhibitors (PubMed Search)

Posted: 10/3/2020 by Ashley Martinelli
Click here to contact Ashley Martinelli

Nitroglycerin is a potent vasodilator used most commonly for the treatment of angina and ACS.  It can also be administered as a continuous infusion for acute management of a hypertensive emergency or sympathetic crashing acute pulmonary edema.  

 

Most are aware of asking men for history of medications for erectile dysfunction (PDE5 inhibitors: sildenafil, tadalafil, vardenafil) but many overlook the fact that men and women may be on these medications chronically for pulmonary hypertension. Men can also be on these medications for the treatment of BPH. Be broad in your history taking and do not limit the discussion to erectile dysfunction or a specific gender.

 

Drug interaction:

-PDE5 inhibitors prevent the breakdown of cGMP

-Nitrates are nitric oxide donors that increase the production of cGMP

-The combination can lead to excessive vasodilation

 

If accidentally co-administered:

There is no antidote for this medication error.  Support the patient with Trendelenburg positioning, fluid administration, and if needed, vasopressors such as norepinephrine until blood pressure stabilizes.

 

How long should you wait to administer nitrates after a patient takes a PDE5 Inhibitor?

Sildenafil and vardenafil: 24 h after last dose*

Tadalafil > 48 h after last dose*

*Even if acute ACS event

Show References



Acute appendicitis is the most common etiology requiring urgent abdominal surgery in children in the United States. Peak incidence occurs in the second decade of life, with male patients being more commonly affected than female patients. Classic manifestations of appendicitis occur in school-aged children and adolescents, but are often absent in younger children. Infants and young children <5 years are more likely to present with nonspecific or atypical findings, resulting in delays in diagnosis and higher rates of perforation.

Diagnosis is aided by clinical factors, lab findings, and ultrasound (+/- CT or MRI if ultrasound is equivocal).

Historically, the standard of care for acute appendicitis has been urgent operative management. However, in the past several years, there has been increasing literature supporting nonoperative management (antibiotics only) in adult patients with acute uncomplicated appendicitis. Additionally, there is a growing body of evidence demonstrating the safety and efficacy of nonoperative management for uncomplicated appendicitis in children.

Hartford and Woodward provide a review of the current literature on the nonoperative management of uncomplicated appendicitis in children. They conclude:

-       The majority of recent prospective studies demonstrate early treatment success (0-30 days) of approximately 90% in pediatric patients undergoing nonoperative management.

-       Factors associated with failure of nonoperative management in pediatric appendicitis: longer duration of symptoms (>48 hours), younger age (<5 years), and presence of appendicolith.

-       Nonoperative management has been associated with

o   Lower healthcare costs at 1 year

o   Fewer disability days at 1 year

o   No significantly different rate of complicated appendicitis

-       Most trials to date involve a 24-48 hour initial course of broad spectrum IV antibiotics followed by oral antibiotics for a total of >/= 7 days as nonoperative management. Currently, there is no consensus on antibiotic regimen.

Bottom Line: Given the current evidence, nonoperative management may be a viable treatment option for low risk pediatric patients with uncomplicated appendicitis. The literature is not conclusive, thus we as medical providers in conjunction with our surgical colleagues, should consider numerous factors when discussing treatment options for acute appendicitis with patients and their families.

Show References



Question

Historically, there has been debate on transporting outside hospital cardiac arrests, as well a trauma, with the question of whether to "scoop and run" or "stay and play". 

Could hasty transportation of cardiac arrest patients put a damper on resuscitation quality? 

A recent propensity-matched study in JAMA analyzed 192 EMS agencies across 10 N American sites.

Methods:

-Resuscitation Outcomes Consortium Cardiac Epidemiologic Registry, which counted 43,969 consecutive cases of nontraumatic adult EMS-treated OHCA (median age 67, 37% of whom were women) in 2011-2015.

-25% of these patients were transported to the hospital

-Matched 1:1 with patients in refractory arrest who were resuscitated on scene 

-Primary outcome was survival to hospital discharge, secondary outcome survival to hospital discharge with a favorable neurological status 

 

Results:

-Duration of out-of-hospital resuscitation was only 6 minutes longer in the intra-arrest transport group (29.1 and 22.9 minutes; not a statistically significant difference)

-Survival to hospital discharge was 3.8% for patients who underwent intra-arrest transport and 12.6% for those who received on-scene resuscitation

-In the propensity-matched cohort, which included 27,705 patients, survival to hospital discharge occurred in 4.0% of patients who underwent intra-arrest transport vs 8.5% who received on-scene resuscitation (risk difference, 4.6% [95% CI, 4.0- 5.1])

-Favorable neurological outcome occurred in 2.9% of patients who underwent intra-arrest transport vs 7.1% who received on-scene resuscitation (risk difference, 4.2% [95% CI, 3.5%-4.9%])

-Intra-arrest transport during resuscitation was associated with worse odds of survival to hospital discharge compared to on-scene resuscitation (4% vs 8.5%, RR 0.48, CI 0.43-0.54)

-Findings persisted across subgroups of initial shockable rhythm vs. non-shockable rhythms (most common initial rhythm was aystole), as well as EMS witness arrests vs. unwitnessed arrests 

 

Conclusion:

-This study does not support the routine transportation of patients in cardiac arrest during rescuscitation.

-The neurologically intact survival benefit associated with on-scene resuscitation is both impressive and intriguing.

-However, what implications could this have on ECPR? 

 

Limitations:

-Potential bias due to observational nature of study 

-Duration of resuscitations very similar, unknown exactly how long transport times were or if this was in urban or rural populations

-External validity not generalizable due to heterogeneity of patient populations and EMS systems

-Further randomized clinical trials are required

Show Answer

Show References



Category: Orthopedics

Title: Physical injury patterns associated with physical elder abuse

Keywords: Elder abuse, bruising, trauma (PubMed Search)

Posted: 9/26/2020 by Brian Corwell, MD (Updated: 5/16/2024)
Click here to contact Brian Corwell, MD

Physical injury patterns associated with physical elder abuse

 

Elder abuse is both common and underrecognized

Between 5 and 10% of US older adults are victims of elder abuse annually

For many older adults, contact with a health care provider may represent their only contact outside the home

Differentiating physical elder abuse from unintentional trauma can be very difficult

A recent study compared these two groups with a case-control design

Study cases: 100 successfully prosecuted physical elder abuse cases from a single urban ED

Physical abuse victims were more likely to have:

               Bruising (78% vs. 54%)

               Injuries to maxillofacial, dental or neck region (67% vs. 28%)

                              Particularly the LEFT side

                              Neck injuries 6x more common is assault

                              Ear injuries occurred in assault but not in falls

               Absence of fracture (8% vs. 22%)

               Less likely to have lower extremity injuries (9% vs. 41%)

22% of victims had no visible injuries

Most common mechanism assault with hands or fists and pushing or shoving causing a fall

Take home: Consider elder abuse especially in cases of the above red flags

              

              

 

 

Show References



Category: Toxicology

Title: Black urine!

Keywords: Black urine, toxicological cause (PubMed Search)

Posted: 9/24/2020 by Hong Kim, MD
Click here to contact Hong Kim, MD

Question

 

What medication ingestion can lead to black urine?

 

Black urine due to cresol intoxication | Postgraduate Medical Journal

Show Answer

Show References


Attachments

2009241429_Black_urine.docx (115 Kb)



Category: Neurology

Title: CVT Presentation and Management

Keywords: cerebral venous thrombosis, CVT, symptoms, treatment, endovascular (PubMed Search)

Posted: 9/23/2020 by WanTsu Wendy Chang
Click here to contact WanTsu Wendy Chang

  • We've talked about the rising incidence of cerebral venous thrombosis (CVT) and choice of neuroimaging studies before, now let’s talk about presentation and treatment.
  • Symptoms range from headache to coma with cerebral edema and intracranial hypertension depending on the veins and sinuses involved.
    • Superior sagittal sinus is most frequently affected (62%) and can cause headache, hemiparesis, hemisensory loss, hemianopia, and seizures.
    • Transverse sinus is also commonly involved (45%) and can cause headache, aphasia, and seizures.
    • Thrombosis of the deep veins is seen in 18% of cases and can cause altered mental status, coma, and gaze palsy.
  • Management includes anticoagulation, treatment of underlying cause, seizures, and intracranial hypertension.
    • LMWH is preferred unless in patients with renal dysfunction or need for rapid reversal of anticoagulation.
    • Endovascular intervention may be considered in severe cases that do not improve or deteriorate despite anticoagulation.
  • Poor prognostic factors are: 
    • 2 points each - malignancy, coma, deep venous thrombosis
    • 1 point each - mental status disturbances, male, intracranial hemorrhage
    • Score ≥3 suggests high risk of poor outcome

Bottom Line: Severity of CVT presentation depends on the location and clot burden. Anticoagulation is key, though consider endovascular intervention if patient does not improve or deteriorates despite anticoagulation.

 

Show References



A retrospective study analyzed data from 757 patients with spontaneous intraparenchymal hemorrhage.

Within the first 6 hours of admission, patients who had systolic blood pressure reduction between 40 – 60 mm Hg (OR 1.9, 95% CI 1.1-3.5) or reduction ≥ 60 mm Hg (OR 1.9, 95%CI 1.01-3.8) were associated with almost double likelihood of poor discharge functional outcome (defined as modified Rankin Scale 3-6).

Additionally, large systolic blood pressure reduction ≥ 60 mm Hg in patients with large hematoma (≥ 30.47 ml) was associated with higher likelihood of very poor functional outcome (mRS 5-6).

Take home points: while more studies are still needed to confirm these observations, perhaps we may not want to drop blood pressure in patients with spontaneous intraparenchymal hemorrhage too much and too fast.

Show References



Systematic review and meta-analysis of 5 studies with a total of 929 patients comparing early vs. late initiation of norepinephrine in patients with septic shock

  • all were single-center studies
  • included RCTs, prospective and retrospective cohort studies

Primary outcome:

  • short-term mortality of the early group was lower than that of the late group ([OR] = 0.45; 95% CI, 0.34 to 0.61)

Secondary outcome:

  • no difference in ICU LOS
  • time to achieved target MAP of the early group was shorter than that of the late group (mean difference = − 1.39; 95% CI, −1.81 to −0.96)
  • in the three studies that assessed the volume of intravenous fluids within 6 h, the volume of intravenous fluids within 6 h of the early group was less than that of the late group (mean difference = − 0.50L; 95% CI, −0.68 to −0.3)

Caveat:

  • no clear definition of “early” initiation (ranged from within 1 to 6 hrs)

Take home point:

Early norepinephrine usage may improve mortality in septic shock

Show References



Category: Pediatrics

Title: Prepubertal Urethral Prolapse

Keywords: prepubertal vaginal bleeding, mass (PubMed Search)

Posted: 9/18/2020 by Jennifer Guyther, MD (Updated: 5/16/2024)
Click here to contact Jennifer Guyther, MD

- Urethral prolapse will appear as a protrusion of the distal urethra through the urinary meatus causing a “doughnut” sign.

- Risk factors include trauma, UTI, anatomical differences, and increased intraabdoiminal pressure from cough or constipation.  There is a higher incidence in people of African descent.

- The chief complaint may include urethral mass and vaginal bleeding.

- There is a bimodal age distribution (prepuberty and postmetapause) due to a relative estrogen deficiency.

-Treatment is with estrogen cream and sitz baths for 4- 6 weeks.

Show References



Category: Orthopedics

Title: Thoracic Spine Fractures in the Panscan Era

Keywords: Spine fracture, decision rule (PubMed Search)

Posted: 9/12/2020 by Brian Corwell, MD (Updated: 5/16/2024)
Click here to contact Brian Corwell, MD

A recent study looked at thoracic spinal fractures in the era of the trauma panscan

NEXUS Chest CT Study from 2011 to 2014 at 9 Level I trauma centers.

Goal: To describe the identification rate and types of thoracic spine fractures.

Inclusion: age over 14 years, blunt trauma occurring within 6 hours of ED presentation, and chest CT imaging during ED evaluation.

11,477 subjects, 217 (1.9%) had a thoracic spine fracture

The majority of spine fractures in patients who had both chest x-ray and CT were observed on CT only (91%). 50% had more than 1 thoracic spinal level involved (mean 2.1). 22% had associated cervical fractures and 25% had associated lumbar fractures.

               64% had vertebral body fractures

               45% had posterior column fractures

               28% had compression fractures

               6% had burst fractures

Many patients (62%) had associated thoracic injuries such as

               Rib fractures (45%)

               PTX (36%)

               Clavicle fracture (18%)

               Scapular fracture (17%)

               Hemothorax (15%)

 

100 patients had clinically significant thoracic spine fractures.

 

Thoracic spine fractures are relatively uncommon in adult patients with blunt trauma.

If thoracic spine fracture is suspected clinically, radiography is not an effective screen and clinician should consider CT. If not suspected, guidelines discourage ordering CT to screen for this injury because of effective screening instruments, the diagnosis of clinically insignificant injuries and radiation exposure.

All clinically significant thoracic spine fractures would have been detected by the NEXUS Chest CT decision instrument.

 

https://www.mdcalc.com/nexus-chest-ct-decision-instrument-ct-imaging

 

Show References



Category: Toxicology

Title: Trend of ECMO use for poisoning in the US: 2000 to 2018

Keywords: ECMO, poisoning, trend in US (PubMed Search)

Posted: 9/10/2020 by Hong Kim, MD (Updated: 5/16/2024)
Click here to contact Hong Kim, MD

 

Extracorporeal membrane oxygenation use is increasing in the US for acute poisoning. 

A retrospective study of the National Poison Data System from 2000 to 2018 identified 407 ECMO cases (332 adults – age > 12 years, 75 pediatric – age < 12 years). Increase in ECMO use were more notable in adult population.

 

Characteristics

  • Median age: 27 years (IQR: 15-39)
  • Male: 52.6%
  • Single substance exposure: 51.5%
  • Median number of exposures: 3 (IQR: 2-4)
  • Overall survival: 70%

Intentional exposure

  • Age > 12 years: 72.6%
  • Age < 12 years: 9.3%

Most common class of drug/poison exposure in adults

  • Sedative/hypnotic: 26%
  • Antidepressants: 25%
  • Calcium channel blockers: 19%
  • Opioids: 17%

Most common class of drug/poison exposure in children

  • Hydrocarbons: 37%
  • Antiarrhythmics: 15%
  • Antihistamine: 8%
  • Unknown: 8%

Most common states that used ECMO for poisoning

  • Pennsylvania: 45
  • Texas: 27
  • Minnesota: 24
  • Maryland: 22
  • Michigan: 20
  • New York: 20

 

Conclusion

  • Increase in EMCO use was most notable in patients with age > 12 years
  • There was no significant trend in mortality during the study period
  • ECMO cases were mostly reported from urban areas 


Category: Neurology

Title: The Rising Incidence of Cerebral Venous Thrombosis

Keywords: cerebral venous thrombosis, CVT, prothrombotic, headache (PubMed Search)

Posted: 9/10/2020 by WanTsu Wendy Chang
Click here to contact WanTsu Wendy Chang

  • Cerebral venous thrombosis (CVT) is thought to predominantly affect young and middle-aged females. 
    • Known risk factors include prothrombotic states such as malignancy and oral contraceptive use, as well as local infections and head trauma.
  • The incidence of stroke in young adults is rising worldwide.
  • A recent study by Otite et al. examined the incidence of CVT during 2006-2016 in New York and Florida utilizing the State Inpatient Database.
    • CVT remains an uncommon condition though number of admissions increased 70%.
    • Mean age of patients increased with number of hospitalizations in the elderly doubled.
    • Incidence was highest in Blacks, followed by non-Hispanic Whites and Hispanics.
  • This rise in incidence may be related to increased recognition, improved diagnostic studies, increased neuroimaging utilization, emerging or unknown risk factors. 

Bottom Line: The incidence of CVT is increasing with rate of increase higher in males and older females.  Consider CVT beyond traditional risk factors. 

 

Show References



Category: Critical Care

Title: VExUS to Detect Venous Congestion

Keywords: resuscitation, ultrasound, VExUS, venous congestion (PubMed Search)

Posted: 9/8/2020 by Kami Windsor, MD
Click here to contact Kami Windsor, MD

 

While the invasive monitoring of central venous pressure (CVP) in the critically ill septic patient has gone the way of also transfusing them to a hemoglobin of 10 mg/dL, it remains that an elevated CVP is associated with higher mortality1,2 and renal failure.2,3

Extrapolating from existing data looking at hepatic vein, portal vein, and renal vein pulsatility as measures of systemic venous hypertension and congestion,4,5,6 Beaubien-Souligny et al. developed the venous excess ultrasound (VExUS) grading system incorporating assessment of all 3, plus the IVC, using US to stage severity of venous congestion in post-cardiac surgery patients.7 They evaluated several variations, determining that the VExUS-C grading system was most predictive of subsequent renal dysfunction.

 

(Image from www.pocus101.com)
 

High Points

       VExUS Grade 3 (severe) venous congestion:

  • Correlated with higher CVP & NTproBNP levels, as well as overall fluid balance
  • Had a 96% specificity for development of subsequent AKI

 

Caveats

  • Evaluating all parameters yields the most benefit to avoid false positives
  • Can be difficult to obtain all views (>25% of subjects excluded due to poor US image quality)
  • Studied in a limited population, notably not primarily RV failure patients

 

Clinical Uses

  • To limit harmful fluid administration in shock
  • To help answer the prerenal vs cardiorenal AKI question in CHF
  • To indicate when volume removal (diuresis) should be the strategy, even in patients with vasopressor-dependent shock

 

A great how-to can be found here:

https://www.pocus101.com/vexus-ultrasound-score-fluid-overload-and-venous-congestion-assessment/

 

Show References



Category: Pharmacology & Therapeutics

Title: Esmolol for Refractory Ventricular Fibrillation (VF) or Pulseless Ventricular Tachycardia (VT)

Keywords: esmolol, cardiac arrest, ventricular tachycardia, ventricular fibrillation (PubMed Search)

Posted: 9/5/2020 by Ashley Martinelli (Updated: 5/16/2024)
Click here to contact Ashley Martinelli

Patients with cardiac arrest due to VF/VT have a higher likelihood of survival compared to those with unshockable rhythms.  Unfortunately some will still not survive even with following the AHA/ACLS algorithms leading to “refractory VF/VT.”  The survival rate of refractory VF/VT is 3-15%, with poor neurologic outcomes. 
 
Esmolol has been proposed as a treatment for the electrical storm of VF/VT to counteract the deleterious effect of beta receptor stimulation by epinephrine.
 
A recent meta-analysis of 3 trials of beta-blockade vs control patients for refractory VF/VT found:
 
Beta-blockade
N=22
Control
N= 44
OR/CI
Temporary ROSC, n (%)
19 (86.4)
14 (31.8)
OR 14.46, 95% CI 3.63-57.57
Sustained ROSC, n (%)
13 (59.1)
10 (22.7)
OR 5.76, 95% CI 1.79-18.52
Survival with neurological function, n (%)
6 (27.3)
4 (9.1)
OR 4.42; 95% CI 1.05-18.56
 
Takeaway: Esmolol needs to be studied further in prospective trials, but may be reasonable to attempt in refractory VF/VT.
 
Esmolol products:
§  Esmolol vial: 10 mg/mL (10mL)
o   Vial strength listed in mg, not mcg
o   Can cause complications with calculations, especially in high risk code scenario
§  Conversion of mg à mcg weight à based calculation 500mcg/kg
§  Do not ask anyone to do this calculation during a code!
§  Esmolol pre-made infusion: 2500 mg/250mL
o   Pump is set up to deliver weight based doses in mcg/kg
o   No mental math required!
 
How to do it at UMMC to limit mistakes in calculation:
1.       Obtain an esmolol pre-made infusion bag
2.       Program the pump for 50 mcg/kg/min continuous infusion (this is a required step in pump programming)
3.       Program the pump to give a 500 mcg/kg bolus x 1
4.       Permit the background infusion to run
5.       Can give an additional bolus of 500 mcg/kg x 1 and increase rate to 100 mcg/kg/min depending on clinical response

Show References



Category: Pediatrics

Title: Temporizing Measures for Button Battery Ingestions

Keywords: button battery, pediatrics, esophageal injuries (PubMed Search)

Posted: 9/4/2020 by Prianka Kandhal, MD
Click here to contact Prianka Kandhal, MD

Ingestion of a button battery is a can't-miss diagnosis with a very high risk for causing severe esophageal injury. There are about 3000 button battery ingestions per year, and this is increasing because electronics are becoming more and more prevalent.

Severe damage to the esophagus occurs within 2 hours. On your lateral view, the end with narrowing is the negative end, which triggers a hydrolysis reaction that results in an alkaline caustic injury and, ultimately, liquefactive necrosis.

Children can present with nonspecific symptoms and if the ingestion was not witnessed, they are at high risk for delays in diagnosis. Additionally, in the community setting, there can be further delays in definitive treatment (endoscopic removal) due to difficulty in calling teams in or transporting to other facilities.

Anfang et al. looked into ways to mitigate damage to esophageal tissue. They did an in vitro study on porcine esophageal tissue, measuring the pH with different substances applied. They tried apple juice, orange juice, gatorade, powerade, pure honey, pure maple syrup, and carafate. They then repeated the study in vivo on piglets with button batteries left in the esophagus and ultimately did gross and histological examination of the esophageal tissue.

Honey and carafate demonstrated protective effects both in vitro and in vivo. They neutralized pH changes, decreased full-thickness esophageal injury, and decreased outward extension of injury into deep muscle.

Take Home Point: If a child is found to have a button battery in the esophagus, while definitive management is still emergent endoscopic removal, early and frequent ingestion of honey (outside of the hospital) and Carafate (in the hospital) may help reduce the damage done to the tissue in the interim. The authors recommend 10ml every 10 minutes.

Show References



Category: Critical Care

Title: Early vs. Standard initiation of renal replacement therapy

Keywords: Renal Replacement Therapy (PubMed Search)

Posted: 9/1/2020 by Kim Boswell (Updated: 5/16/2024)
Click here to contact Kim Boswell

STARRT-AKITrial

The Standard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury

The development of acute kidney injury (AKI) in the critical care setting portends a greater morbidity and mortality for patients. Additionally, it places the patient at high risk of complications and requires a greater use of resources. Several studies in the past have examined if the timing of initiation of renal replacement therapy (RRT) would result in a mortality benefit, but have failed to demonstrate consistent outcomes.

The STARRT-AKI trial was a multinational, randomized controlled trial designed to determine if early initiation of RRT in critically ill adult patients with AKI lowered the risk of 90-day mortality. The Kidney Disease Improving Global Outcomes (KDIGO) classification was used to define AKI and over 2900 patients were randomly assigned to two groups over a 4 year period. Exclusion criteria included: recent RRT, a renal transplant within the preceding year, advanced CKD, an overdose necessitating RRT, or a strong suspicion of obstruction or autoimmune/vascular cause of their AKI.

Groups:

  • The accelerated strategy group
    • Initiation of RRT within 12 hours of meeting eligibility criteria (AKI based on KDIGO definition)
  • The standard strategy group –
    • General goal of withholding RRT unless the patient met the following specific parameters:
    • K+ >6.0,  pH <7.20,  HCO3 <12mmol/L,  moderate ARDS with clinical picture concerning for volume overload, or persistent AKI >72hr after randomization

Outcomes/Results:

  • The study’s primary outcome measure was all cause mortality at 90 days
    •  There was no significant difference between the groups
    •  P=0.92 with RR 1.00
  • Secondary outcomes evaluated several things including ventilator and vasoactive free days, hospital length of stay, number of days without RRT at 90 days as well as adverse events directly related to RRT
    • Interestingly, at 90 days, the patients in the accelerated strategy group were more likely to have ongoing RRT needs at 10.4% compared to the standard strategy group at 6.0% (not statistically significant).
    •  Overall, no significant difference between the groups when assessed for death in the ICU, major adverse events, or with regard to hospital length of stay.

Take home points:

  • This was a well done, well randomized trial from many countries and ICU settings
  • No significant mortality benefit between groups at 90 days
  • Interestingly, the patients in the accelerated group were more likely to have suffered adverse events related to RRT and were more likely to be dependent on RRT at 90 days
    • It is unclear why this is, but suggestive that early initiation of RRT may compromise the intrinsic healing of the kidney
    • Emphasizes a greater risk for adverse events without clear benefit
  • Ultimately, the decision to initiate RRT should be based on the patient’s clinical picture, acid/base status, electrolyte abnormalities, and volume status and NOT on a general trend of their renal indices.

Show References



Category: Neurology

Title: The Painful Twitch - Trigeminal Neuralgia

Keywords: trigeminal neuralgia, TN, tic douloureux, neuropathic facial pain (PubMed Search)

Posted: 8/26/2020 by WanTsu Wendy Chang
Click here to contact WanTsu Wendy Chang

  • Trigeminal neuralgia is diagnosed by:
    • Pain in 1 or more divisions of the trigeminal nerve
    • Paroxysms of pain that are sudden, intense, usually few seconds in duration
    • Pain triggered by innocuous stimuli in the trigeminal nerve territory (91-99% patients)
  • 24-49% of patients experience continuous or long-lasting pain
  • Exam may reveal forceful contraction of the facial muscles during a paroxysm (tic convulsif)
  • Causes include:
    • Intracranial vascular compression of the trigeminal nerve root (most common)
    • Multiple sclerosis, cerebellopontine angle tumor
    • Idiopathic (10% of cases)
  • Carbamazepine and oxcarbazepine are first-line treatments
    • They may be poorly tolerated due to side effects including dizziness, diplopia, ataxia, CNS depression, and hyponatremia
    • They also have limited efficacy on continuous pain
  • Acute exacerbations may warrant admission for hydration, acute pain control, and titration of antiepileptic drugs
    • Botulinum toxin A was recently added as a treatment option

Bottom Line: New onset trigeminal neuralgia needs workup for its etiology. Carbamazepine and oxcarbazepine can be effective for symptom management though continuous or long-lasting pain exacerbations are difficult to treat.

Show References



Ketamine In the Critically Ill Patient

  • Ketamine has become a popular agent in the ED for both RSI and procedural sedation.
  • Given the sedative, analgesic, dissociative, antidepressant, and anti-inflammatory properties, ketamine has also been used in a number of other critical illness conditions including:
    • Acute pain management
    • Status asthmaticus
    • Alcohol withdrawal syndrome
    • Status epilepticus
    • Acute agitated delirium
  • The authors of a recent review in Critical Care Medicine found that the evidence supporting the use of ketamine in the critically ill is most robust for adjunctive analgesia in the intubated patient.  Surprisingly, the data is very limited to support the use of ketamine in these other conditions.
  • Pearl: ketamine does have a myocardial depressant effect, which can be unmasked in states of catecholamine depletion and result in hypotension and bradycadia.

Show References